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Introduction
RhoGTPases regulate many aspects of the actin cytoskeleton and membrane organization and thus control cell polarity, behaviour, morphology and division (Jaffe and Hall, 2005) . Switching between an inactive GDP-bound and an active GTP-bound conformation, Rho proteins activate effector enzymes like protein kinases, formins and other cytoskeletal regulators as well as different scaffold proteins (Bustelo et al., 2007) . Important for the cellular organization and behaviour is the spatial and temporal control of Rho activation, which is achieved by a balance of GEF and GAP enzymes at selected membrane domains (Schmidt and Hall, 2002a; Tcherkezian and Lamarche-Vane, 2007) .
Although it is clear that Rho activation is spatially and temporally regulated, the exact molecular mechanisms that underlie this tight control are not well defined. A prominent example of locally regulated Rho activation is cytokinesis of animal cells (D'Avino et al., 2005) . Here the separation of the two newly formed daughter cells is achieved by the assembly of a contractile ring in the cleavage plane of the mother cell followed by constriction and subsequent scission. The activity of a Rac specific GAP, which is a component of the centralspindlin complex as well as the activity of the RhoGEF Ect2/Pebble are required to form a narrow zone of Rho activation at the overlaying cell cortex. Rho activation is a prerequisite for the assembly of the actomyosin filaments that drive constriction (Bement et al., 2005; Kamijo et al., 2006; Lee et al., 2004; Somers and Saint, 0925-4773/$ -see front matter Ó 2010 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2010.01.001
2003; Tatsumoto et al., 1999) . In addition to the spatial control of Rho activity, the temporal regulation is equally essential, especially during development. During the epithelial to mesenchymal transition (EMT) in avian gastrulation, RhoA is localized basally in pre-EMT epiblast cells by the RhoGEF Net1 (Nakaya et al., 2008) . One suggested mechanism to regulate Rho activity in the cytoplasm is the nuclear sequestration and signal dependent cytoplasmic release of GEFs like Pebble and Net1 (Prokopenko et al., 1999; Schmidt and Hall, 2002b) . However, this type of regulation cannot account for the control of the polarized localization of GEFs and their restricted activation at membrane domains. This means that additional mechanisms assure the proper spatial and temporal control of GEF activity.
Drosophila cellularization offers an excellent system to study Rho activation in a developmental context. Early embryonic development of Drosophila starts with a series of 13 rapid nuclear divisions that proceed in a common cytoplasm without cytokinesis. After 13 divisions the cell cycle pauses and during interphase of cell cycle 14 the somatic nuclei of the syncytial blastoderm that are arranged as a cortical monolayer are enclosed into cells by invagination of the plasma membrane in a process called cellularization (Mazumdar and Mazumdar, 2002) . At the onset of interphase 14 similar as in previous interphases filamentous actin forms caps at the cortex apically to the nuclei. Within the next few minutes f-actin is reorganized and gradually accumulates at the tip of the invaginating membrane, the furrow canal (Schejter and Wieschaus, 1993; Warn and Magrath, 1983) . This reorganization of the actin cytoskeleton depends on Rho1. Inhibition of Rho1 function by drugs or expression of dominant-negative alleles leads to a disruption of the actin cytoskeleton and to severe defects during membrane invagination (Crawford et al., 1998) . We and others have described previously the functions of RhoGEF2 and the Rho1 effector Dia during blastoderm formation of Drosophila embryos (Afshar et al., 2000; Grosshans et al., 2005; Padash Barmchi et al., 2005) . In RhoG-EF2 mutants the furrow canals are often incorrectly formed and sometimes missing. Rho1 fails to localize to the furrow canal and the levels of furrow canal associated f-actin are reduced. RhoGEF2 is a large multidomain protein with homology to the mammalian LARG and with multiple developmental functions. Beside its role in cellularization, RhoGEF2 is involved in apical constriction of cells that precedes mesoderm invagination during Drosophila gastrulation when it receives input from the small G protein Concertina (Barrett et al., 1997; Hä cker and Perrimon, 1998; Kö lsch et al., 2007) . Furthermore, it was shown to be involved in the formation of segmental grooves during mid-embryogenesis (Mulinari et al., 2008) as well as in epithelial invagination during salivary gland formation and in the formation of a proper wing epithelium (Nikolaidou and Barrett, 2004) . So far different models have been proposed to explain how RhoGEF2 and thus Rho activation is targeted to specific membrane compartments. One is based on the observation that GFP-RhoGEF2 is dynamically associated with microtubule plus ends in S2 cells in an EB1 dependent manner and that this association can be released by the activated form of the Ga subunit Concertina. It has been suggested that this mechanism might be involved in the RhoGEF2 mediated apical constriction of presumptive mesoderm cells (Rogers et al., 2004) . Targeting proteins to certain membrane domains by MT plus end mediated transport has been reported in other systems (Shaw et al., 2007) , however, the physiological significance of the MT plus end localization has not yet been confirmed in a living organism. A second model suggests that a recycling endosome dependent vesicle transport mechanism contributes to the localization of RhoGEF2 to metaphase furrows during syncytial divisions. This is based on studies that showed that localization of RhoGEF2 to metaphase furrows is disturbed in nuf and Rab11 embryos (Cao et al., 2008) . Here we show that the localization of RhoGEF2 at the furrow canal is required for the protein function during cellularization. We identified the PDZ domain of RhoGEF2 as the domain necessary and sufficient for furrow canal localization. Furthermore, we present evidence that the localization of RhoGEF2 at the furrow canal is controlled by Slam. Interestingly slam belongs to a group of early zygotic genes whose expression peaks during cellularization. Slam is required for timely invagination of the membrane furrows (Lecuit et al., 2002; Stein et al., 2002) . Besides a functional relation, we also show that Slam can interact with the PDZ domain of RhoGEF2 in vivo. Finally, we show that slam mRNA shows a unique furrow canal localization suggesting a mechanism, where the polarized membrane localization of slam transcripts mediates RhoGEF2 localization, which in turn controls Rho activity during furrow canal formation.
Results

The PDZ domain targets RhoGEF2 to the furrow canal
We and others have previously reported that RhoGEF2 contributes to the assembly of actin-myosin at the furrow canal by Rho1 mediated activation of the formin Dia, which is necessary to keep the proper morphology of the furrow canal (Grosshans et al., 2005; Padash Barmchi et al., 2005) . To analyze how RhoGEF2 is targeted to the site of membrane invagination, we established an mRNA microinjection assay with myc-tagged constructs for testing RhoGEF2 localization (Fig. 1A) . mRNA encoding full-length RhoGEF2 was injected into embryos from RhoGEF2 germline clones (Fig. 1B) . Since the full-length construct localized to the furrow canal as marked by co-staining for f-actin (Fig. 1B 0 ), this assay can be employed for mapping the localization element. In a second step four constructs spanning the coding sequence of RhoGEF2 were injected (Fig. 1A) . All four constructs showed differential localization ( Fig. 1C-F) , only the N-terminal construct myc-RG2-1 accumulated in a pattern resembling full-length protein localization (Fig. 1C) . We then used two constructs spanning the sequence of the construct myc-RG2-1 that were designed with a partial overlap containing the PDZ domain (data not shown). Since both constructs showed a similar furrow canal localization we concluded that the PDZ domain might be sufficient for mediating this localization. To confirm this hypothesis, we tested a construct encoding only the PDZ domain fused to the myc 6 tag. This protein of about 28 kDa could be detected mainly in the nucleus (data not shown). To circumvent the nuclear accumulation, we added more copies of the PDZ domain thereby increasing the molecular weight of the resulting fusion protein. This also increased the affinity for the furrow canal binding sites, since we observed a reduction in cytoplasmatically localized protein. All tested constructs containing 2 or 4 copies of the PDZ domain fused to myc 6 could be detected at the furrow canal ( Fig. 1G and H) , thus confirming that the PDZ domain is sufficient for furrow canal localization. To test the influence of different protein tags, we injected mRNA encoding a GST-2xPDZ RG2 -myc 6 construct (Fig. 1H ).
Moreover we tested the localization dynamics in vivo by using a fly strain that expressed a UAS-4xPDZ RG2 -RFP transgene driven by a maternal Gal4 driver ( Supplementary Fig. S1A-D) . Both constructs showed the expected furrow canal localization. To test whether the PDZ domain is also required for localization of full-length RhoGEF2, two amino acid residues of the carboxylate loop of the PDZ domain were mutated to generate myc 6 -RhoGEF2(GAGA) ( Fig. 2A) . These residues are essential for ligand binding in the PDZ domain of the rat protein rPDZRhoGEF (Longhurst et al., 2006) . This construct was expressed under the control of the ubiquitously active spagetti-squash promoter in germline clones of a RhoGEF2 null allele (RhoGEF2
04291
). Since the mutated protein was not enriched at the furrow canal ( Fig. 2C and G) , the PDZ domain is indeed required for localization of RhoGEF2. Moreover the PDZ domain is required for RhoGEF2 function, since in contrast to a respective wildtype construct ( Fig. 2E and I ), the myc 6 -RhoGEF2(GAGA) transgene does not restore the furrow array during cellularization and thus does not complement the mutant phenotype ( Fig. 2G and K) . Moreover myc-RhoGEF2-T1544A, a RhoGEF2 allele with a point mutation in the guanyl-nucleotide exchange domain (Grosshans et al., 2005) , localized correctly but did not complement the RhoGEF2 phenotype ( Fig. 2F and J) . This experiment shows that the multidomain protein RhoGEF2 indeed requires the Rho1 specific GEF activity for its function during cellularization. 
2.2.
Slam is required for RhoGEF2 localization at the furrow canal PDZ domains are involved in assembling membrane associated signalling complexes by mediating protein-protein interactions (Jelen et al., 2003) . To find factors that could be responsible for the PDZ-mediated furrow canal localization of RhoGEF2, we reinvestigated the role of Slam, a protein that is required for germ cell migration and for timely invagination of the plasma membrane during cellularization. The (PDZ Dlg2 ) and the first PDZ of Bazooka (PDZ Baz1 ). The consensus sequence is given in the bottom line (Xunspecified, U-hydrophobic). Top line: two residues in the PDZ domain of RhoGEF2 (green) were substituted to generate mycRhoGEF2(GAGA). (B and C) Embryos from transgenic flies expressing either myc-RhoGEF2 (B) or myc-RhoGEF2(GAGA) (C) in wildtype background were stained for myc-tag or the furrow canal marker Slam. myc-RhoGEF2 localization is indistinguishable from endogenous RhoGEF2 (J, Grosshans et al., 2005) . (D-G) The localization of the different myc-RhoGEF2 alleles was tested by staining for myc. The furrow canal is marked by a-Yrt staining (Laprise et al., 2006) . No myc-signal is detected in RhoGEF2 embryos (D) whereas myc-RhoGEF2 and myc-RhoGEF2(T1544A) both localize at the furrow canal (E and F). In contrast myc-RhoGEF2(GAGA) does not localize to the furrow canal (G). (H-K) Myc-tagged RhoGEF2 constructs were expressed as transgenes in a RhoGEF2 amorphic background. The embryos shown are not the same embryos as in D-G. The presence of multinuclear cells in cellularizing embryos was scored to analyze the rescue activity of theses alleles. Embryos were fixed and stained for f-actin. In RhoGEF2 embryos multinuclear cells are present in 100% of counted embryos (H, n = 52). Expression of myc-RhoGEF2 fully complements this phenotype (I, n = 25), whereas expression of myc-RhoGEF2(T1544A) (J, n = 35) and myc-RhoGEF2(GAGA) (K, n = 15) did not. Scale bars: 10 lm.
2002).
Slam mutant embryos showed strongly reduced RhoGEF2 staining at the furrow canal in direct comparison to their heterozygous or wildtype siblings ( Fig. 3A and B), whereas levels of the lateral furrow marker Neurotactin (Nrt) remained relatively unaffected (Fig. 3C ). We obtained similar results after staining for the lateral furrow marker Dlg, since the levels of Dlg and its localization to the lateral membrane were comparable in wildtype and in slam embryos ( Supplementary  Fig. S2A -J). Consistent with previous reports (Lecuit et al., 2002) , Nrt was apically enriched in slam mutants ( Fig. 3C ; white arrowhead). The residual RhoGEF2 levels that were detectable in slam embryos may be due to the low maternal contribution of slam or to a redundant ligand. Testing the reverse relationship, we found that Slam localized normally in embryos from RhoGEF2 germline clones (Fig. 6N) . The functional dependance of RhoGEF2 on Slam appears to be dosedependent, since embryos with a Slam gradient along the anterior-posterior axis that was induced by posterior injection of slam dsRNA showed a corresponding RhoGEF2 gradient (Fig. 3E and F) . Since other proteins such as Myosin II and Patj that are localized at the furrow canal were also dependent on slam ( Fig. 3G ; Supplementary Fig. S3H and K), two possibilities are conceivable to explain the observed functional relation between RhoGEF2 and Slam. One explanation could be that furrow canal localization of RhoGEF2 depends specifically on Slam due to a direct or indirect protein interaction. Alternatively the furrow canal is simply absent or dysfunctional, which would result in a non-specific loss of all furrow canal markers. To further analyze the link of Slam and RhoGEF2 we tested RhoGEF2 localization in germline clones of slam waldo1 , a slam allele with a premature stop codon (Stein et al., 2002) . The levels and the prominent accumulation of the truncated Slam protein at the furrow canal were lower than in wildtype embryos ( Supplementary Fig. S3A , D, G and J). RhoGEF2 enrichment at the furrow canal was strongly reduced, while Patj staining was almost absent (Supplementary Fig. S3B , E, H and K), indicating that Slam differentially controls furrow canal localization of RhoGEF2 and Patj.
2.3.
Slam and PDZ RG2 interact biochemically
One possible mechanism that could explain the observed functional relation between RhoGEF2 and Slam is that RhoGEF2 gets recruited to the furrow canal by a physical interaction with Slam. To test this hypothesis, we isolated Slam complexes by immunoprecipitation from staged embryos. We raised an antibody against Slam and tested this antibody for specificity in Western blots (Fig. 4A) . A band at an apparent molecular weight of above 175 kDa could be detected, which is higher than the predicted molecular weight of 130 kDa. Nevertheless in extracts from embryos expressing a GFP-Slam fusion protein a second band with an apparent higher molecular weight is detected in addition to the 175 kDa band. This band can also be detected by using an anti-GFP antibody. Slam waldo1 was reported to contain a premature stop codon, which should result in a truncated protein with a predicted size of about 80 kDa. In embryonic extracts from slam waldo1 germline clones we could detect a second band of about 100 kDa in addition to the 175 kDa band of full-length Slam (Fig. 4B) . The slam waldo1 extract also contains full-length Slam protein, since zygotically homozygous and heterozygous embryos were not sorted. Taken together these results show that our antibody is specific for Slam. Since the full-length RhoGEF2 protein cannot be robustly detected in Western blots with embryonic extracts, we employed transgenic embryos expressing a 4xPDZ RG2 -myc 6 fusion protein for immunoprecipitation experiments (Fig. 4C ). This fusion protein showed a more exclusive localization at the furrow canal than the full-length RhoGEF2 protein ( Fig. 1B and G) . Slam protein was enriched in the bound fraction. We found that the PDZ construct and Patj, which like RhoGEF2 depends on Slam for its localization, were enriched in the bound fraction. Other proteins like Dia and Dlg fully remained in the unbound fraction. This experiment shows that Slam, Patj and 4xPDZ RG2 -myc 6 are part of the same biochemical complex in the tested embryos. Given that 4xPDZ RG2 -RFP localizes similarly as RFP-RhoGEF2 ( Supplementary Fig. S1 ) the In the co-IP performed using the preimmune serum a weak association of 4xPDZ RG2 -myc 6 was detected (lane 5). The sample volume loaded in lane 1-4 corresponds to 10 embryos, in lanes 5 and 6 to 500 embryos.
RhoGEF2 to ectopic sites. First we locally injected mRNA encoding a myc-tagged Slam construct into wildtype embryos to increase the Slam levels ( Fig. 5A-C) . Correspondingly the staining levels for endogenous RhoGEF2 at the furrow canal increased (Fig. 5B) , what shows that Slam controls RhoGEF2 levels in a dosage dependent manner. This is consistent with the RhoGEF2 levels of embryos where Slam was gradually downregulated by dsRNA injection (Fig. 3E and F) . Proteins containing PDZ domains often interact with transmembrane proteins that contain a PDZ binding motif at their cytoplasmic tail (Jelen et al., 2003) . Slam is a novel membrane associated protein (Lecuit et al., 2002) without any known functional domains. Nevertheless, it contains a potential class II PDZ binding motif at its C-terminus (-AVEV). Using our injection assay we directly compared the activity of a wildtype construct to a slam allele with a mutated C-terminus (-AAEA). The mRNA encoding the wildtype allele was injected at the posterior pole, the mRNA encoding the mutant allele, at the anterior pole (Fig. 5D-F) . Staining of such embryos for RhoGEF2 shows that both slam alleles can equally recruit additional RhoGEF2 to the furrow canal (Fig. 5E ). This suggests that the recruitment of RhoGEF2 by Slam does not occur via a conventional direct interaction between the PDZ of RhoGEF2 and the putative PDZ binding motif at the C-terminus of Slam.
To test whether Slam is sufficient for RhoGEF2 localization, we established a recruitment assay in cultured cells, which did not show any detectable slam expression. Under the fixation conditions used, both endogenous (data not shown) and transiently expressed myc-tagged RhoGEF2 are uniformly distributed in the cytoplasm with no obvious enrichment at the plasma membrane ( Fig. 5L and N) . Co-expression of GFP-Slam, which displayed a sharp peripheral distribution (Fig. 5O ), lead to a corresponding peripheral enrichment of myc-RhoGEF2 protein ( Fig. 5P and R) in the vast majority of the cells (Fig. 5J ). This ectopic recruitment of RhoGEF2 was confirmed by expression of slam in the embryonic epidermis. Upon expression of a UAS-Slam-HA construct by a prd-GAL4 driver in seven stripes of epidermal cells Slam-HA localizes to structures at the basal end of epidermal cells, whose nature and function are unknown (Fig. 5G-I ). The cells between the stripes serve as a staining control. Co-staining for RhoGEF2 shows that there is a strong correlation of Slam and RhoGEF2 ( Fig. 5H and I) . Taken together these experiments show that ectopically localized Slam protein can either directly or indirectly recruit RhoGEF2 and that this recruitment does not depend on the C-terminus of Slam.
Slam deficient embryos exhibit aspects of the RhoGEF2 phenotype
If RhoGEF2 depends on Slam in functional terms, at least some aspects of the mutant phenotype of RhoGEF2 will be visible in the slam mutants. In embryos from RhoGEF2 germline clones, there are gaps in the furrow array that lead to the formation of multinuclear cells (Grosshans et al., 2005) . Close examination of embryos from slam waldo1 germline clones showed that indeed gaps in the furrow array are observed mostly in the ventral region ( Fig. 6A-D) . Although the gaps resemble the RhoGEF2 mutant phenotype, such a regional bias is not observed in embryos from RhoGEF2 germline clones. Triggered by the recent report that nullo is required for separation of basal and lateral membrane markers (Sokac and Wieschaus, 2008b), we reexamined the RhoGEF2 mutant phenotype. We found that similar as in nullo embryos, the lateral marker protein Dlg, which is normally excluded from the furrow canal and does not overlap with Patj, Slam or RhoGEF2 (Fig. 6E and F) , extended into the furrow canal in embryos from RhoGEF2 germline clones (Fig. 6G) . In slam mutant embryos a similar distribution of Dlg was observed (Fig. 6I ). Although these experiments do not show that these aspects of the slam mutant phenotype are caused by lacking RhoGEF2 function, they show that slam is involved in the same processes as RhoGEF2.
A third aspect of the phenotype of a RhoGEF2 null mutant is that Rho1 does not localize at the furrow canal (Fig. 6O) . This aspect of the phenotype is specific for RhoGEF2 since Rho1 does localize normally in nullo mutants (data not shown). In contrast, we find that furrow canal levels of Rho1 are clearly reduced in slam mutants (Fig. 6R and U) . The protein is not completely absent, since low levels of RhoGEF2 are present at the furrow canal in slam zygotic mutants. Taken together, these data suggest that specific aspects of the complex slam phenotype can be explained by the loss of the spatial control of Rho1 activity at the furrow canal, which might be based on a direct or indirect interaction between Slam and RhoGEF2.
2.6.
Slam RNA and protein accumulate at the prospective site of invagination If Slam mediates the accumulation of RhoGEF2 at the prospective furrow canal, the question arises how Slam itself localizes at these sites. By reexamining the temporal and spatial expression pattern of slam, we found that Slam protein is present in low levels before the onset of the strong zygotic expression. These low levels may reflect a maternal contribution. During mitosis 13, Slam staining was found at the metaphase furrows (data not shown) and at the interphase furrows in early cycle 14 (Fig. 7B) . We observed an almost exclusive staining at the furrow canal and no staining at the lateral furrow. Besides the staining at the furrow canal, particles of various size basal to the nuclei were stained especially in the first part of cycle 14 (Fig. 7B) . Strikingly, we found the same distribution when we stained for slam mRNA by fluorescent RNA in situ hybridization (Fig. 7A and D) . Co-staining of slam mRNA and protein showed an extensive match and a stronger protein staining at the furrow canal as compared to the basal particles, especially in later embryos ( Fig. 7C and F) . These findings are consistent with the previously described slam mRNA localization in blastoderm embryos (Takada et al., 2007) . The overlapping RNA and protein distribution may suggest that Slam mRNA is involved in Slam protein localization at the furrow canal.
Discussion
RhoGEF2 is an essential regulator of Rho1 activity during many different stages of Drosophila development including cellularization (Barrett et al., 1997; Dawes-Hoang et al., 2005; Grosshans et al., 2005; Hä cker and Perrimon, 1998; Nikolaidou and Barrett, 2004; Padash Barmchi et al., 2005) . However, little has been known about the events and factors that control RhoGEF2 localization and subsequent Rho1 activation at the furrow canal. Here we assign a new function to the PDZ domain of RhoGEF2 in being sufficient and required for furrow canal localization. The pattern and the dynamics of furrow canal localization of different PDZ RG2 containing constructs are very similar to that of endogenous RhoGEF2 thereby reflecting the behaviour of the full-length protein during cellularization. The domain could be used to effectively target other proteins like RFP, myc or GST to the furrow canal. Thus despite being a multidomain protein, furrow canal localization depends ultimately only on residues that assure the structural integrity of the ligand recognition site of the PDZ domain. It was reported previously that the RhoGEF2 PDZ domain is involved in the subcellular localization of RhoGEF2 during apical constriction of mesodermal cells in gastrulation (Kö lsch et al., 2007) . It has been suggested that a direct interaction between the PDZ domain and the PDZ binding motive at the C-terminus of the apically localized transmembrane protein T48 is involved in the recruitment of RhoGEF2 to the apical site of the cells. However, it is clear that this interaction is not essential for apical RhoGEF2 localization, since this localization is lost only in T48/cta double mutants.
By using immunoprecipitations from staged embryonic extracts we could show that a transgenic 4xPDZ RG2 -myc 6 construct can physically interact with Slam in vivo. Of course this does not directly proof that Slam also interacts with fulllength endogenous RhoGEF2. Nevertheless we present different arguments that support the assumption that a physical interaction between Slam and RhoGEF2 underlies the observed functional relationship between these two factors in cellularizing embryos. As described above the PDZ domain is the critical element that mediates the localization of RhoGEF2 at the furrow canal where it colocalizes with Slam. We could show that this PDZ domain can form a complex with Slam in vivo. Further in vivo experiments confirmed that furrow canal localization of RhoGEF2 depends on slam in a dosage dependent manner which supports the biochemical findings. Moreover Slam can recruit RhoGEF2 to ectopic sites in embryos as well as in S2 cells and we can observe aspects of the RhoGEF2 mutant phenotype in slam deficient embryos. Overall we think it is reasonable to conclude that there is the possibility of a direct or indirect interaction between Slam and RhoGEF2 during formation of the cellular blastoderm. This interaction would be mediated by the PDZ domain of RhoGEF2. Our data also demonstrate that slam acts upstream of RhoGEF2.
The molecular function of slam has remained unknown, although the essential role of this gene in cellularization is well established (Merrill et al., 1988) . It has been proposed that Slam is involved in membrane traffic, since in slam mutants the polarized insertion of membrane is disturbed (Lecuit et al., 2002) . Here we describe an additional cell biological function of slam in being a developmental switch that temporally and spatially controls Rho activity in blastoderm embryos by regulating the subcellular localization of the Rho1 activator RhoGEF2. Thus by proposing the existence of a protein complex containing RhoGEF2 and Slam, we can link physiological and molecular function of Slam.
PDZ domains often interact with the C-termini of transmembrane proteins. There are different classes of PDZ binding motifs that can be classified according to their amino acid composition (Jelen et al., 2003) . Although not being a transmembrane but a membrane associated protein (Lecuit et al., 2002) , Slam posseses a potential class II PDZ binding motif at its C-terminus. However, this motif seems to be dispensable for the recruitment of RhoGEF2 by Slam to ectopic sites. This is consistent with the fact that a slam allele with a mutated C-terminus rescued the cellularization phenotype of slam deficient embryos (data not shown). In addition this allele was able to recruit RhoGEF2 to the furrow canal membrane. Furthermore we can observe RhoGEF2 to be still present although with reduced levels at the furrow canal in germline clones of a C-terminally truncated slam allele slam waldo1 . Besides the interaction between Slam and the PDZ domain of RhoGEF2, we also observed an interaction between Slam and Patj in our co-IPs from staged embryonic extracts. This is consistent with the fact that both proteins almost perfectly colocalize during cellularization at the furrow canal as well as in basal particles ( Supplementary Fig. S3G and H) . Furthermore we also see a functional relation between Slam and Patj, since Patj levels at the furrow canal are reduced in embryos that are zygotically deficient for slam. Patj is a conserved protein that contains 4 PDZ domains and was previously reported to be able to interact with Crumbs in vitro and in vivo during epithelial polarity establishment later in development (Bhat et al., 1999) . However, the importance of this interaction remains unclear, since embryos that are maternally and zygotically mutant for Patj have been reported to develop until adulthood without obvious phenotypes (Pielage et al., 2003) . This would argue against an essential role of Patj during cellularization. As shown by another report, the mutants used in the study mentioned above still expressed a truncated Patj protein that contained the first PDZ domain thus it is likely that residual Patj function was still present (Nam and Choi, 2006) . Zygotic Patj null mutants, in which the coding sequence of Patj was removed completely, died during second instar larval stage, indicating that Patj is an essential gene. Therefore it would be worth to generate maternal Patj null mutants to investigate the role of this protein during cellularization in more detail. Nevertheless the interaction between Patj and Slam seems to depend mainly on the C-terminus of Slam, since in slam waldo1 mutants Patj levels at the furrow canal are strongly reduced ( Supplementary Fig. S3H and K). Thus it is possible that the putative PDZ binding motif at the C-terminus of Slam is important for a direct interaction with one of the PDZ domains of Patj. The Slam Patj interaction also shows that besides controlling RhoGEF2 localization Slam has other independent functions, which could account for the strikingly stronger cellularization phenotype of slam mutants compared to the weaker phenotype of RhoGEF2 deficient embryos.
As mentioned previously RhoGEF2 also functions in different epithelial invagination processes like salivary gland formation or in the establishment of the epithelium in the wing imaginal disc of Drosophila L3 larvae. It appears likely that the subcellular localization of the protein is controlled by genes encoding different receptors that are expressed during different developmental stages in a tissue specific manner like slam or T48 which would allow a very precise temporal and spatial regulation of Rho activity by employing the same ubiquitously expressed activating factor. RhoGEF2 also has a function in the maternally controlled formation of the metaphase furrows during the cleavage divisions 10-13 of the syncytial blastoderm stage and it was shown that localization of the protein to these furrows depends on maternal components of the recycling endosome (Cao et al., 2008) . The start of zygotic slam expression at the onset of cellularization thus could assure that sufficient levels of RhoGEF2 and thus Rho activity become associated with the membrane tip during invagination. At the same time the metaphase furrows that have recently been shown to be rather active endocytic membrane domains (Sokac and Wieschaus, 2008a) are transformed into a domain forming the furrow canal, which were reported to be much more inactive and stable (Lecuit and Wieschaus, 2000) .
Here we also describe that slam transcripts show a new and unique mRNA localization pattern. A significant portion of slam mRNA is associated with the furrow canal membrane domain (also described in Takada et al., 2007) . Surprisingly the initial processes that ensure a local restriction of Rho activity would be the proper localization of the slam RNA/protein particles. The asymmetrical localization of transcripts within a cell often linked with localized translation is an important mechanism for the spatial regulation of gene activity. Apical localization of transcripts during cellularization has been described for a number of genes including wg, run and ftz (Wilkie and Davis, 2001) . Here the transcripts are transported to localize to the apical cytoplasm of the cells of the cellular blastoderm. However, little is known about the functional importance of this transcript localization. The localization of slam transcripts might also include a basal to apical transport step, since we can observe large basal particles containing slam mRNA and protein in cellularizing embryos. It has been reported previously that apical Rho activity during posterior spiracle formation is mediated in part by RhoGEF64C. The transcript of this gene does localize to the apical membrane of the epithelial cells which undergo apical constriction and subsequent invagination (Simoes et al., 2006) . The mechanisms that ensure the association of transcripts with a specific membrane domain remain to be solved and slam would offer a good system to study this question. Future studies will show whether and how the localization of slam mRNA is involved in defining the sites for membrane invagination and what other functions are served by slam besides initiating Rho signalling.
Taken together, we propose a model for the developmental control of Rho1 signalling at the furrow canal, in that the slam RNA-protein particles are targeted to the prospective site of membrane invagination at the onset of cellularization. Slam would have several functions, mainly initiating the formation of the furrow canal as a distinct membrane domain by regulating membrane traffic and at the same time it would recruit and restrict RhoGEF2 and maybe other factors to this domain. After reaching a critical concentration the GEF activity would be activated by a yet unknown mechanism. Rho1 would be converted into its GTP-bound form and downstream targets like Dia or Rho-kinase would be activated. Consistent with this model is our observation that the dose-dependent activity of Slam, both higher or lower than normal levels, directly corresponds to the amount of RhoGEF2 protein and the speed of cellularization as for example shown by the local injection of slam RNA.
4.
Experimental procedures
Genetics
OreR flies were used as wildtype controls in Western blots and in some of the immunostainings. Transgenic fly strains were generated by P-element mediated germ line transformation (Rubin and Spradling, 1982) (Chou and Perrimon, 1996) . For scoring the rescue activity of different myc-tagged RhoGEF2 alleles a third chromosomal insertion of the respective construct was crossed into the RhoGEF2 
Histology
Embryos were fixed either in 4% formaldehyde in PBS or by heat treatment (for RhoGEF2, Nrt and myc-RhoGEF2 stainings) as previously described (Grosshans et al., 2005) . S2 cells were fixed for 10 min in 4% formaldehyde in PBS, permeabilized in 0.5% Triton X100 in PBS for 30 s, blocked with 5% BSA in PBT (PBS + 0.1% Tween20) for 15 min and then incubated with the primary antibody in PBT for 1 h. After washing with PBT and incubation with the secondary antibody for 1 h cells were stained with DAPI for 3 min, washed again and finally mounted in Aqua Polymount (Polysciences). Fluorescence RNA in situ hybridization was performed according to (Tautz and Pfeifle, 1989) . In brief, after the post-hybridization washes, embryos were incubated twice with PBT + 1% BSA for 20 min each at RT and then incubated for 2 h with a-DIG antibody coupled to peroxidase. After that embryos were washed 3· for 1 min and 4· for 15 min with PBT. Staining reaction was started by adding 200 ll of reaction solution (TSA-Cy3 diluted 1:200 in reaction buffer, PerkinElmer) to the embryos for 5-10 min. Embryos were washed 3· with PBT and then used for subsequent antibody co-staining.
The following antibodies were used: Primary antibodies: rabbit-a-RhoGEF2 (Grosshans et al., 2005) , guinea pig-a-Slam, rabbit-a-Slam (Brandt et al., 2006) , mouse-a-Dlg (Hybridoma Center), mouse-a-myc-9E10 (Roche), mouse-a-Nrt (Hybridoma Center), rabbit-a-Patj (kindly provided by H. Bellen, described in Bhat et al., 1999) , mouse-a-Myo (gift from B. Mechler), rabbit-a-Dia (Grosshans et al., 2005) , rabbit-a-GFP (Torrey Pines Biolabs), mouse-a-HA (Babco), mouse-a-Rho1 (Magie et al., 2002 ) and rat-a-Yrt (gift from U. Tepass, described in Laprise et al., 2006) , secondary antibodies: Alexacoupled goat-anti-mouse, goat-anti-rabbit and goat-antiguineapig (Invitrogen), POD coupled a-Digoxygenin Fab-fragments (Roche). F-actin was stained using Alexa-coupled phalloidin (Invitrogen) and DNA was stained using DAPI.
Microinjections
Embryos were injected as previously described (Grosshans et al., 2005) . The mRNA constructs were injected at concentrations of about 0.5-2 lg/ll. Slam dsRNA was injected at the posterior pole at a concentration of 1 lg/ll.
4.4.
Cell culture Drosophila S2 cells were kept in Schneiders Drosophila medium (Gibco/Invitrogen) supplemented with 10% fetal bovine serum (Gibco/Invitrogen) at 25°C. Cells were transiently transfected either with pCaSpeR-sqh-myc 6 -RhoGEF2 or with pMT-GFP-Slam and pCaSpeR-sqh-myc 6 -RhoGEF2 using the Qiagen Effectene Transfection Reagent (Qiagen). After 18-24 h the reagent was removed and cells were seeded on uncoated cover slips. GFP-Slam expression was induced by addition of 0.5 mM CuSO 4 to the medium. Sixteen hours later cells were fixed and used for immunostaining.
Imaging
A Zeiss Axiovert 200 M PerkinElmer Ultra-View Spinning Disc konfocal microscope (63· NA 1.4 oil Apochromat and 100· NA 1.4 oil) was used for timelapse recordings of embryos expressing RFP fusion proteins, as well as for imaging of fixed and immunostained S2 cells (flatfield capture mode). Fluorescence was excited using 488 and 546 nm laser light. For live imaging z-stacks of 5-10 images covering a distance of 5-10 lm were recorded. Appropriate layers were subsequently selected for further analysis. Fluorescent images of fixed and immunostained embryos were recorded with a Leica confocal microscope (DMIRE2, HCX PL APO 63· NA 1.4 oil, laser at 405, 488, 568, 633 nm). Images were processed with ImageJ and Adobe Photoshop.
Immunoprecipitation
Embryonic extracts were prepared by lysing 100 mg of 2-3 h old embryos in RIPA buffer (10 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.1% SDS, 1% Triton X 100, 1% Deoxycholate, 5 mM EDTA, 2 mM PMSF, 1· protease inhibitor cocktail complete Mini EDTA-free, Roche) in a Dounce homogenizer. The suspension was centrifuged for 15 min at 20,000g to remove debris. The supernatant was immediately used for IP-experiments. Guinea pig-a-Slam antibody (serum) or preimmune serum was coupled to Protein-A-Sepharose beads (GE Healthcare) in PBT for 1 h at 4°C. Beads were washed five times with PBT before freshly prepared embryonic extract was added. The samples were incubated on a rotator for 60 min at 4°C. A sample was taken from the supernatant (unbound fraction). Beads were then washed 3 times with dilution buffer (10 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1 mM freshly added PMSF, 1· protease inhibitors) and 2· with washing buffer (10 mM Tris/HCl pH 7.5, 300 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, 1· protease inhibitors). Bound proteins were eluted in 50 ll laemmli buffer and analyzed using SDS-PAGE and subsequent Western blotting.
Molecular genetics
A detailed list of all constructs used in this study is included in the Supplementary data. The dsRNA probe directed against slam was generated as previously described (Lecuit et al., 2002) using the T7 MEGAscript High Yield Transcription Kit (Applied Biosystems). Capped transcripts were synthesized using the SP6 mMESSAGE mMACHINE high yield capped RNA transcription kit (Applied Biosystems).
